Aquestive Therapeutics (AQST) PT Raised to $15 at JMP Securities, Following Clinical Business Update
Tweet Send to a Friend
JMP Securities analyst Jason N. Butler raised the price target on Aquestive Therapeutics (NASDAQ: AQST) to $15.00 (from $14.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
